Exosomes: promising evidence, and a regulatory question to ask first

What an exosome treatment is

Exosomes are extracellular vesicles — small packages released by cells, carrying proteins and genetic material that influence the behaviour of other cells. The idea in aesthetics is to use that signalling to prompt repair: more collagen, better hydration, less pigment.

The sources vary enormously between products. The published literature covers vesicles derived from stem cells, platelets, plants, and milk. Two products both labelled "exosome" may have very little in common, which is a theme of this page.

They are used two different ways, and the difference matters more than the marketing suggests: applied to skin after a procedure that has opened it, or injected into it.

What the evidence shows

A systematic review published in January 2026 in Dermatology Practical & Conceptual screened 1,032 papers and included 21, spanning laboratory work, animal models, clinical trials and retrospective evaluations across several countries including South Korea.

The direction of the findings is consistently positive:

• Elasticity — increases from 11.3% to 104% depending on the study
• Wrinkles — around 16% reduction in wrinkle index
• Hydration — 19–21% increases
• Pigmentation — reductions of up to 36% in one study
• Consistent upregulation of collagen types I and III

Safety in those studies was good: mild, transient redness, swelling and dryness, with no serious adverse events reported.

Then the reviewers name their own limits, and they are the sort that should slow you down: small sample sizes, heavy reliance on in-vitro and animal models rather than people, no standardised protocol for characterising what the vesicles in a given product actually are, and short follow-up.

An elasticity range spanning 11% to 104% is not a measurement of a treatment. It is a measurement of several different things sharing a name.

The question to ask before efficacy

For someone being offered this in South Korea, there is a prior question, and this is the part no clinic page will raise.

Is the product licensed as a drug, or registered as a cosmetic?

Reporting on the Korean market says that exosome products used in clinics are commonly registered as cosmetics, that no exosome drug has been approved for human use, and that the Ministry of Health and Welfare has stated injecting a product that is not a drug into the body with a syringe is contrary to medical law and may constitute unethical medical practice. The same reporting describes a doctor who injected an exosome-containing cosmetic receiving a three-month licence suspension, upheld when challenged.

Two cautions on how to read that, because it is serious enough to state precisely:

• This is reporting, not a primary government document. It is consistent across outlets and quotes the ministry directly, but this site distinguishes what it has read from what it has been told, and this is the latter.
• It turns on the specific product and how it is used. Applying a cosmetic topically after a procedure is a different act from injecting it. A licensed drug, if one exists, is a different case again.

What follows is not "avoid exosomes". It is that you are entitled to know which situation you are in, and it takes one question to find out.

How to check

1. Ask for the Korean product name, in writing.
2. Ask whether it is licensed as a drug or registered as a cosmetic.
3. Ask whether it will be applied to your skin or injected into it.
4. Look the name up on the ministry's drug portal. A product that does not appear there is not licensed as a drug, whatever else it may be.

A clinic that answers all four plainly is a clinic worth continuing with. Hesitation on the second question is itself an answer.

Where this sits against the alternatives

If what you want is skin quality, the alternatives have different profiles rather than better ones. Polynucleotide injectables have a thin but real clinical literature and a clear regulatory position. Hyaluronic acid boosters have controlled trial evidence. Microneedle radiofrequency has the largest evidence base of anything in this area and no ambiguity about what it is.

None of that makes exosomes a bad idea. It makes them an early one, sold ahead of both their evidence and, in South Korea, ahead of a settled regulatory position.

The bottom line

Exosome therapies show consistent promise across 21 studies for elasticity, wrinkles, hydration and pigmentation, with mild side effects and no serious adverse events reported — but the studies are small, lean heavily on laboratory and animal work, and do not standardise what is being measured. In South Korea the more urgent question is regulatory: ask whether the product is licensed as a drug or registered as a cosmetic, and whether it is being applied or injected, before you agree to anything.